Multimeric Apo A-I agonist compounds
US7307058B2 · kind B2 · utility
7Cited by
0References
23Claims
0Family size
Inventors
Key dates
| Filing date | Nov 17, 2003 |
| Grant date | Dec 11, 2007 |
| Priority date | — |
| Expiry date | Apr 25, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.